Hetzer Medical Indonesia Tbk. vs Capitalinc Investment Tbk. — how do they compare? Hetzer Medical Indonesia Tbk. trades at Rp86 (market cap 139.06B, 51.66M 24h volume), while Capitalinc Investment Tbk. trades at Rp13 (market cap 413.95B, 21.34M 24h volume). The key difference: Capitalinc Investment Tbk. is far larger — about 3× Hetzer Medical Indonesia Tbk.'s market cap, and Hetzer Medical Indonesia Tbk. is more actively traded (51.66M versus 21.34M). Which is the better fit depends on your goals.
| MEDS | MTFN | |
|---|---|---|
Market Cap | 139.06B | 413.95B |
Volume | 51.66M | 21.34M |
Lot | 516.62K | 213.43K |
Turnover | 4.44B | — |
Average Price | 85.97 | — |
Value | 4.44B | — |
Indicative Equilibrium Price | 86 | — |
Indicative Equilibrium Volume | 9.62K | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Hetzer Medical Indonesia Tbk (the Company) was established based on Notarial Deed of Cahya Suryana, S.H., Notary in Bandung, No. 12 dated December 31, 2010.
Read more on MEDS →PT Capitalinc Investment Tbk formerly PT Bakrie Finance Corporation Tbk hereinafter called the Company was established based on deed No.15 dated November 11, 1993 of Notary Soedarno, SH. The deed of establishment was approved by the Minister of Justice of the Republic of Indonesia in his decree No. C2.7999-HT.01.01.Th.83 dated December 12, 1983 and was published in the State Gazette of the Republic of Indonesia No.4 dated January 13, 1984, Supplement No.35.Before the amendment in its articles of association, the scope of its activities include leasing, factoring receivable and consumer financing. The Company obtained its operating license as a financial institution from the Minister of Finance of the Republic of Indonesia through decree No.295/KMK.013/1990 dated March 3, 1990. In line with the change in the Company’s scope of activities, the Company’s financing activities have been transferred to PT Swadinamika Bakrie Finance, a subsidiary.
Read more on MTFN →